This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (12)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Psychiatry, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

No News Is Good News

Arch Gen Psychiatry. 2000;57:319-320.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

IN THIS issue of the ARCHIVES, Kahn et al¹ summarize the findings of their analysis of primary and supervisory review documents and memoranda, authored by Food and Drug Administration clinical and statistical staff, that were obtained under the Freedom of Information Act from the files of 7 antidepressant New Drug Applications approved between 1987 and 1997. The authors undertook their analysis in an effort to determine whether there was any evidence within the agency's reviews of the comprehensive reports that drug sponsors make to the Food and Drug Administration to support the suspicion/belief, widely prevalent among those who question the ethical propriety of placebo-controlled trials, that patient-subjects randomized to placebo are at greater risk of injury and/or suffer greater substantive discomfort than those assigned to other experimental treatment conditions.

For those like myself who are persuaded that the concurrently randomized, placebo-controlled trial is essential to the reliable evaluation of the . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Symptom Reduction and Suicide Risk in Patients Treated With Placebo in Antidepressant Clinical Trials: An Analysis of the Food and Drug Administration Database
Arif Khan, Heather A. Warner, and Walter A. Brown
Arch Gen Psychiatry. 2000;57(4):311-317.
ABSTRACT | FULL TEXT  

The Placebo Problem Remains
Karin B. Michels
Arch Gen Psychiatry. 2000;57(4):321-322.
EXTRACT | FULL TEXT  

What Conditions Are Necessary to Assess Antidepressant Efficacy?
Frederic M. Quitkin and Donald F. Klein
Arch Gen Psychiatry. 2000;57(4):323-324.
EXTRACT | FULL TEXT  

Suicide and Antidepressant Treatment
Robert M. A. Hirschfeld
Arch Gen Psychiatry. 2000;57(4):325-326.
EXTRACT | FULL TEXT  

Statistical Analysis to Settle Ethical Issues?
Helena Chmura Kraemer
Arch Gen Psychiatry. 2000;57(4):327-328.
EXTRACT | FULL TEXT  

Placebo Protects Subjects From Nonresponse: A Paradox of Power
Andrew C. Leon
Arch Gen Psychiatry. 2000;57(4):329-330.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ethical aspects of placebo groups in pain trials: Lessons from psychiatry
Nagasako and Kalauokalani
Neurology 2005;65:S59-S65.
ABSTRACT | FULL TEXT  

Depression: An Update for the Clinician
Nierenberg et al.
Focus 2005;3:3-12.
FULL TEXT  

Placebo Response in Studies of Major Depression: Variable, Substantial, and Growing
Walsh et al.
JAMA 2002;287:1840-1847.
ABSTRACT | FULL TEXT  

The Undiscovered Mind: How the Human Brain Defies Replication, Medication, and Explanation
FORREST
Am. J. Psychiatry 2002;159:333-334.
FULL TEXT  

Pharmacologic Treatment of Traumatized Children
COHEN
Trauma Violence Abuse 2001;2:155-171.
ABSTRACT